| Synonyms: | |
| Status: | Approved (2009) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | C10AA08 |
| UNII: | M5681Q5F9P |
Structure
| InChI Key | VGYFMXBACGZSIL-MCBHFWOFSA-N |
|---|---|
| Smile | |
| InChI |
|
Physicochemical Descriptors
| Property Name | Value |
|---|---|
| Molecular Formula | C25H24FNO4 |
| Molecular Weight | 421.47 |
| AlogP | 4.52 |
| Hydrogen Bond Acceptor | 4.0 |
| Hydrogen Bond Donor | 3.0 |
| Number of Rotational Bond | 8.0 |
| Polar Surface Area | 90.65 |
| Molecular species | ACID |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 31.0 |
Pharmacology
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Oxidoreductase
|
- | 4 | - | - | - | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 64 |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Hypercholesterolemia | 3 | D006937 | ClinicalTrials |
| Hyperlipidemias | 3 | D006949 | ClinicalTrials |
| Diabetes Mellitus, Type 1 | 3 | D003922 | ClinicalTrials |
| Ischemic Stroke | 3 | D000083242 | ClinicalTrials |
| Coronary Disease | 3 | D003327 | ClinicalTrials |
| Diabetes Mellitus, Type 2 | 3 | D003924 | ClinicalTrials |
| Lipid Metabolism Disorders | 3 | D052439 | ClinicalTrials |
| Breast Neoplasms | 2 | D001943 | ClinicalTrials |
| Renal Insufficiency | 1 | D051437 | ClinicalTrials |
| Influenza, Human | 1 | D007251 | ClinicalTrials |
| Metabolic Syndrome | 1 | D024821 | ClinicalTrials |
Related Entries
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 147511-69-1 |
| ChEBI | 32020 |
| ChEMBL | CHEMBL1201753 |
| DrugBank | DB08860 |
| DrugCentral | 2214 |
| EPA CompTox | DTXSID1048384 |
| FDA SRS | M5681Q5F9P |
| Human Metabolome Database | HMDB0041991 |
| Guide to Pharmacology | 3035 |
| PubChem | 5282452 |
| SureChEMBL | SCHEMBL3369 |
| ZINC | ZINC000001534965 |
CONTENTS